You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
步長製藥(603858.SH):擬出資950萬元與關聯方共投設控股子公司
格隆匯 12-17 16:25

格隆匯12月17日丨步長製藥(603858.SH)公佈,為契合公司的發展規劃,促進戰略目標的實現,公司擬與他方合作投資設立上海步長移動醫療有限公司(暫定名,以工商註冊登記為準,“上海步長”)。

此外,為了推動公司與各方的利益形成共贏局面,為公司及股東創造最大價值,根據《山東步長製藥股份有限公司股權投資項目跟隨投資管理辦法》的相關規定,薛人琿(公司董事、營銷副總裁)、付巍(公司市場部副總經理、互聯網事業部總經理、國際貿易部總監)、王湛(公司大數據管理中心副總經理)擬對本次投資進行跟投。

其中,公司出資950萬元,持股比例95%;周豔敏出資30萬元,持股比例3%;薛人琿出資5萬元,持股比例0.5%;沙靖軼出資5萬元,持股比例0.5%;付巍出資5萬元,持股比例0.5%;王湛出資5萬元,持股比例0.5%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account